DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM PAR
Total 13F shares
3,456,234
Share change
+2,777,662
Total reported value
$1,591,000
Price per share
$0.46
Number of holders
15
Value change
+$1,272,983
Number of buys
12
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q4 2019

As of 31 Dec 2019, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,456,234 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, BARCLAYS PLC, UBS Group AG, VANGUARD GROUP INC, Creative Planning, and Swift Run Capital Management, LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.